EGFR and pancreatic neoplasm: In the study conducted by Merlin et al. 45, the researchers investigated the role of Gal-3 in regulating the cellular distribution of MUC1 (mucin 1) and EGFR (epidermal growth factor receptor) in pancreatic cancer cells.